Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study

Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study

(2017) Hui-ying Rao et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2016

(2017)   JOURNAL OF HEPATOLOGY

Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions

(2017) Steven W. Johnson et al.   Current Infectious Disease Reports

Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection

(2017) Swee Lin G. Chen Yi Mei et al.   PLoS One

HCV genotype 3: a wolf in sheep’s clothing

(2016) José-R. Blanco et al.   Expert Review of Anti-Infective Therapy

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)

(2016) Vincent Leroy et al.   HEPATOLOGY

APASL consensus statements and recommendation on treatment of hepatitis C

(2016) Masao Omata et al.   Hepatology International

Safety of interferon-free therapies for chronic hepatitis C: a network meta-analysis

(2016) V. L. Ferreira et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection

(2015) Gregory T. Everson et al.   ANNALS OF INTERNAL MEDICINE

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study

(2015) David R. Nelson et al.   HEPATOLOGY

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan

(2015) Heather Bennett et al.   Hepatology International

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

(2015) Graham R. Foster et al.   NEW ENGLAND JOURNAL OF MEDICINE

HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV

(2014) Fasiha Kanwal et al.   HEPATOLOGY

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

(2014) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

(2013) Eric Lawitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis

(2011) A. Probst et al.   JOURNAL OF VIRAL HEPATITIS

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C

(2009) Pierre-Yves Bochud et al.   JOURNAL OF HEPATOLOGY